REQUEST A DEMO
Total
USD $0.00
Search more companies

Onconick Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical and Medicine Manufacturing
Full name: Onconick Sp. z o.o. Profile Updated: May 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Onconick Sp. z o.o. is based in Poland. The head office is in Zlotniki. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on January 21, 2020. A growth of 0.19% was recorded in its total assets.

Headquarters
Ul. Krzemowa 1
Zlotniki; Wielkopolskie; Postal Code: 62-002

Contact Details: Purchase the Onconick Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Onconick Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Onconick Sp. z o.o. report to view the information.
Incorporation Date:
January 21, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
26.11%
Purchase this report to view the information.
18.47%
Purchase this report to view the information.
18.47%
Purchase this report to view the information.
18.47%
Purchase this report to view the information.
18.47%
Company Performance
Financial values in the chart are available after Onconick Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-30014.02%
Net Profit (Loss) for the Period
-437.3%
Total assets
0.19%
Total equity
-0.25%
Return on Equity (ROE)
-0.21%
Quick Ratio
-298.6%
Cash Ratio
-51.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?